Document is current
Any future updates will be listed below
-
Authors
Aldhouse, Natalie V. J. https://orcid.org/0000-0001-6573-7431
Kitchen, Helen
Johnson, Chloe
Marshall, Chris
Pegram, Hannah
Pease, Sheryl
Collins, Sam
Baker, Christine L.
Beaverson, Katherine
Crews, Chandler
Massey, Jill
Wyrwich, Kathleen W.
-
Funding
Funding for this research was provided by:
pfizer inc
- License Information
-
More Information
Article History
Received: 23 July 2021
Accepted: 26 April 2022
First Online: 7 May 2022
Declarations
:
: The study protocol was reviewed and approved by New England Independent Review Board (IRB Protocol Number: 20200883) on 10th April 2020.
: Not applicable.
: NVJA, HK, CJ, CM, and HP are employees and stockholders of Clarivate, a health economic and outcomes research consultancy that consults with various pharmaceutical companies, and were paid consultants to Pfizer in connection with this study and the development of this manuscript. CLB and KB are employees and shareholders at Pfizer. SC, SP and KWW were employees at Pfizer when this research was conducted, and are shareholders at Pfizer. CC and JM have no conflicts of interest to declare.
